TELA Bio (TELA) EPS (Basic) (QoQ) (2018 - 2026)
TELA Bio (TELA) EPS (Basic) (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | TELA Bio | 36.19 Mn | 5.76 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.49% |
| Mar 31, 2026 | -13.11% |
| Dec 31, 2025 | -0.06% |
| Sep 30, 2025 | 13.41% |
| Jun 30, 2025 | 12.10% |
| Mar 31, 2025 | -124.27% |
| Dec 31, 2024 | 344.20% |
| Sep 30, 2024 | 17.82% |
| Jun 30, 2024 | -121.82% |
| Mar 31, 2024 | 62.50% |
| Dec 31, 2023 | -30.60% |
| Sep 30, 2023 | 11.59% |
| Jun 30, 2023 | 18.35% |
| Mar 31, 2023 | -15.68% |
| Dec 31, 2022 | 11.68% |
| Sep 30, 2022 | 16.90% |
| Jun 30, 2022 | 0.16% |
| Mar 31, 2022 | -41.05% |
| Dec 31, 2021 | 30.25% |
| Sep 30, 2021 | 23.21% |